Cargando…

Impact of COVID-19 on the care of patients with liver disease: EASL-ESCMID position paper after 6 months of the pandemic

During the early stages of the coronavirus disease 2019 (COVID-19) pandemic, EASL and ESCMID published a position paper to provide guidance for physicians involved in the care of patients with chronic liver disease. While some healthcare systems are returning to a more normal routine, many countries...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boettler, Tobias, Marjot, Thomas, Newsome, Philip N., Mondelli, Mario U., Maticic, Mojca, Cordero, Elisa, Jalan, Rajiv, Moreau, Richard, Cornberg, Markus, Berg, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402276/ https://www.ncbi.nlm.nih.gov/pubmed/32835190 http://dx.doi.org/10.1016/j.jhepr.2020.100169

Ejemplares similares

Care of patients with liver disease during the COVID-19 pandemic: EASL-ESCMID position paper
por: Boettler, Tobias, et al.
Publicado: (2020)

Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paper
por: Marjot, Thomas, et al.
Publicado: (2022)

Impact of the COVID-19 pandemic on hepatitis B and C elimination: An EASL survey
por: Kondili, Loreta A., et al.
Publicado: (2022)

EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients
por: Cornberg, Markus, et al.
Publicado: (2021)

Thriving in turbulent times: EASL reflects on 2021, looking to 2022 and beyond
por: Berg, Thomas, et al.
Publicado: (2022)

Consensus document for the diagnosis of prosthetic joint infections: a joint paper by the EANM, EBJIS, and ESR (with ESCMID endorsement)
por: Signore, Alberto, et al.
Publicado: (2019)

ESCMID rapid guidelines for assessment and management of long COVID
por: Yelin, Dana, et al.
Publicado: (2022)

The ESCMID ethics advisory committee (EEAC): purpose and challenges
por: Righi, Elda, et al.
Publicado: (2022)

JHEP Reports: A new EASL open access journal
por: Zucman-Rossi, Jessica
Publicado: (2019)

Consensus document for the diagnosis of peripheral bone infection in adults: a joint paper by the EANM, EBJIS, and ESR (with ESCMID endorsement)
por: Glaudemans, Andor W. J. M., et al.
Publicado: (2019)

Guideline review: EASL clinical practice guidelines: drug-induced liver injury (DILI)
por: Brennan, Paul N, et al.
Publicado: (2021)

ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia
por: Martin-Loeches, Ignacio, et al.
Publicado: (2023)

ESCMID COVID-19 living guidelines: drug treatment and clinical management
por: Bartoletti, Michele, et al.
Publicado: (2022)

ESCMID COVID-19 guidelines: diagnostic testing for SARS-CoV-2
por: Fragkou, Paraskevi C., et al.
Publicado: (2022)

Global impact of the first wave of COVID-19 on liver transplant centers: A multi-society survey (EASL-ESOT/ELITA-ILTS)
por: Russo, Francesco Paolo, et al.
Publicado: (2022)

Joint ESCMID, FEMS, IDSA, ISID and SSI position paper on the fair handling of career breaks among physicians and scientists when assessing eligibility for early-career awards
por: Huttner, Angela, et al.
Publicado: (2021)

ESCMID COVID-19 living guidelines: drug treatment and clinical management: author's reply
por: Bartoletti, Michele, et al.
Publicado: (2022)

Humoral and cellular immune responses to SARS-CoV-2 vaccination across multiple vaccine platforms and liver disease types: an EASL registry multicentre prospective cohort study
por: Marjot, Thomas, et al.
Publicado: (2022)

EASL-EASD-EASO Clinical Practice Guidelines for the Management of Non-Alcoholic Fatty Liver Disease
Publicado: (2016)

A national multidisciplinary healthcare network for treatment of hepatitis C in people who inject drugs in Slovenia
por: Maticic, Mojca
Publicado: (2014)

Highlights at the 28th Congress of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), 2018
por: Nabal, Sandra, et al.
Publicado: (2019)

Association between Following the ESCMID Guidelines for the Management of Candidemia and Mortality: A Retrospective Cohort Study
por: Maurille, Charles, et al.
Publicado: (2022)

Modified EASL-CLIF criteria that is easier to use and perform better to prognosticate acute-on-chronic liver failure
por: Thuluvath, Paul J, et al.
Publicado: (2022)

Speakers from low- and middle-income countries should have a greater voice at ESCMID conferences
por: Mendelson, Marc
Publicado: (2021)

Re: ‘ESCMID COVID-19 living guidelines: drug treatment and clinical management’ by Bartoletti et al
por: Dauby, Nicolas
Publicado: (2022)

Next-generation sequencing in routine clinical microbiology and infectious diseases: an ESGMD-ESGEM ESCMID postgraduate course
por: Aamot, Hege Vangstein, et al.
Publicado: (2022)

Organization and training at national level of antimicrobial stewardship and infection control activities in Europe: an ESCMID cross-sectional survey
por: Maraolo, Alberto Enrico, et al.
Publicado: (2019)

ESCMID guidelines on testing for SARS-CoV-2 in asymptomatic individuals to prevent transmission in the health care setting
por: Carrara, Elena, et al.
Publicado: (2022)

Man or machine? Prospective comparison of the version 2018 EASL, LI-RADS criteria and a radiomics model to diagnose hepatocellular carcinoma
por: Jiang, Hanyu, et al.
Publicado: (2019)

What is new in BTS 2017 & ATS/ERS/ESCMID/IDSA 2020 guidelines on treatment of non-tuberculous mycobacterial pulmonary disease?
por: Sharma, Surendra Kumar, et al.
Publicado: (2021)

Management of Clostridioides difficile infection in adults and challenges in clinical practice: review and comparison of current IDSA/SHEA, ESCMID and ASID guidelines
por: Bishop, Emma Jane, et al.
Publicado: (2022)

Outcomes of Liver Transplant Recipients With Acute-on-Chronic Liver Failure Based on EASL-CLIF Consortium Definition: A Single-center Study
por: Agbim, Uchenna, et al.
Publicado: (2020)

T cell and humoral immune response to multiple SARS-CoV-2 variants including omicron (B1.1.529) after two doses of COVID-19 vaccine in patients with cirrhosis and liver diseases requiring immunosuppression: data from the EASL COVID-Hep network
por: Murray, Sam, et al.
Publicado: (2022)

Microbiology in minimally invasive autopsy: best techniques to detect infection. ESGFOR (ESCMID study group of forensic and post-mortem microbiology) guidelines
por: Saegeman, Veroniek, et al.
Publicado: (2021)

EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease: guidelines, clinical reality and health economic aspects
por: Toplak, Hermann, et al.
Publicado: (2016)

Transplantation for EASL-CLIF and APASL acute-on-chronic liver failure (ACLF) patients: The TEA cohort to evaluate long-term post-Transplant outcomes
por: Xia, Lei, et al.
Publicado: (2022)

HMAP, World Hepatitis Day and the bigger health systems picture
por: Lazarus, Jeffrey V., et al.
Publicado: (2016)

A systematic review of Hepatitis C virus treatment uptake among people who inject drugs in the European Region
por: Lazarus, Jeffrey V, et al.
Publicado: (2014)

Hepatitis B Elimination in Children of Slovenian Origin Born in Slovenia After the Introduction of Preventive Strategies: the Results of a National Study
por: Kmet, Nina Grasselli, et al.
Publicado: (2022)

What have we learned from the first to the second wave of COVID-19 pandemic? An international survey from the ESCMID Study Group for Infection in the Elderly (ESGIE) group
por: Tiseo, Giusy, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hmtg12skk13qsabgg9rjh74713